Objectives. Testing for human immunodeficiency virus (HIV) is the key first step in HIV treatment and prevention. In 2006, the Centers for Disease Control and Prevention (CDC) recommended annual HIV testing for people at high risk for HIV infection. We evaluated HIV testing among men with high-risk heterosexual (HRH) contact and sexually active men who have sex with men (MSM) before and after the CDC recommendations.
New infections of human immunodeficiency virus (HIV) occur in the United States at a rate of approximately 50,000 per year, driven mostly by sexual transmission, particularly among men who have sex with men (MSM). 1 In 2010, male-to-male sexual contact accounted for 63% of new HIV infections (78% among males), and heterosexual contact accounted for 25% of new HIV infections (11% among males). 1, 2 Although overall incidence has been relatively stable since 2006, among young MSM, particularly young black MSM, new infections continue to increase. 1, 3 An estimated 14% of adults and adolescents living with HIV infection in the United States are undiagnosed, of whom 11% are males with high-risk heterosexual (HRH) contact and 62% are MSM. 4 To increase the proportion of HIV-infected people who are aware of their status and link them to treatment and prevention services, the Centers for Disease Control and Prevention (CDC) recommended in 2006 that all people aged 13-64 years be tested at least once for HIV infection and that people at high risk for HIV infection, including men with HRH contact and sexually active MSM, 5 be tested annually.
Using data from multiple waves of a nationally representative survey, we examined the percentage of HRH and MSM respondents who reported having been tested for HIV in the prior 12 months. We compared rates of testing before and after the revised HIV testing guidelines 5 were released by CDC in 2006. Additionally, because the 2006 CDC guidelines recommended that HIV screening be conducted as part of routine clinical care in all health-care settings, 5 we examined HIV testing among men stratified by their reported use of health-care services in the prior 12 months and by several sociodemographic variables.
METHODS
We used data from the National Survey of Family Growth (NSFG) for our analysis. 6 NSFG, established in 1971, is a periodic cross-sectional household-based survey, conducted by the National Center for Health Statistics, employing multistage sampling methods to produce a nationally representative probability sample of males and females aged 15-44 years living in the United States. 7, 8 NSFG collects data on sexual behavior and reproductive health through in-person, voluntary, and confidential interviews conducted by trained female interviewers. The most sensitive items of the survey are administered with an audio computer-assisted self-interview to ensure privacy. In 2002, NSFG included men for the first time in its survey history. In 2006, to control costs and increase data quality, NSFG switched to a continuous survey design, in which interviewing was done every year by a smaller number of interviewers working consistently over survey years. We used data from male respondents from two NSFG cycles, Cycle 6 (2002) and continuous Cycle 7 (2006 Cycle 7 ( -2010 . The response rate of male respondents was 78% in 2002 and 75% in 2006-2010. We used NSFG's sampling weights in our analysis to account for the complex sample design to ensure nationally representative estimates. 7 2006, 2007, 2008, 2009, or 2010. Our analysis focused on men at risk for contracting HIV through sex as adapted from risk groups defined in CDC's revised HIV testing guidelines: 5 sexually active MSM, defined as men who reported at least one male partner in the prior 12 months, regardless of whether they self-identified as gay, bisexual, or other; and HRH, defined as men who did not have sex with other men in the prior 12 months and who reported sex in the prior 12 months with multiple female partners; with a female partner who was non-monogamous, injected drugs, or was HIV-infected; or with a female partner in exchange for drugs or money. Men who did not have any sexual risk were defined as men who did not meet the criteria for MSM or HRH. The NSFG surveys did not include a question about current HIV status; thus, we were not able to exclude men who had been diagnosed with HIV infection prior to the survey.
Our primary outcome measure, self-reported HIV testing in the prior 12 months, did not include testing performed as part of blood donation. Stratification variables included receipt of physical examination in the prior 12 months, receipt of testing or treatment for sexually transmitted infections (STIs) other than HIV in the prior 12 months, current health insurance status, and other sociodemographic variables: age, race/ethnicity, income, and sexual identity; and in the prior 12 months, use of injected drugs, a shelter stay, and incarceration. Data on income were dichotomized (annual poverty threshold or annual poverty threshold defined by the U.S. Census Bureau 9 ). For 2006-2010 (but not for 2002), respondents were asked to choose a reason for their most recent HIV test from 13 options.
We used SUDAAN ® version 10 10 to estimate weighted proportions of male respondents who reported receiving HIV testing in the prior 12 months. We conducted the same analysis separately for HRH respondents and for MSM respondents, in which we compared HIV testing between 2002 and three other periods (2002 vs. 2006-2010, 2002 vs. 2006-2008, and 2002 vs. 2008-2010) and assessed correlates of HIV testing using univariate logistic regression. We included variables with a p-value 0.10 in univariate analysis in multivariable logistic regression models. We estimated strength of association with HIV testing using relative risk (RR) based on average marginal predictions. For each of the two NSFG cycles, we weighted estimates for unequal selection probabilities and nonresponse to adjust for the complex NSFG sampling design. We applied weights separately to each cycle before pooling the data from the two NSFG cycles.
In our overall analysis, we combined data from 15 Most HRH respondents (56%, 95% CI 53, 60) and MSM respondents (61%, 95% CI 54, 68)) were non-Hispanic white, followed by Hispanic and non-Hispanic black, and most had annual incomes above the annual poverty threshold (Table 1) . Among HRH respondents, 70% (95% CI 67, 72) had health insurance (private, Medicaid, Medicare, military, or Veterans Administration), 48% (95% CI 46, 51) had received a physical examination in the prior 12 months, and 28% (95% CI 26, 30) had received testing or treatment for an STI other than HIV in the prior 12 months. Among MSM, 58% (95% CI 52, 64) identified as homosexual or gay, 21% (95% CI 17, 25) as bisexual, and 16% (95% CI 11, 22) as heterosexual or straight. Among MSM, 76% had health insurance (private, Medicaid, Medicare, military, or Veterans Administration), 52% (95% CI 46, 59) had received a physical examination in the prior 12 months, and 40% (95% CI 33, 47) had received testing or treatment for STIs in the prior 12 months.
For all years combined, HIV testing occurred in the prior 12 months among 11% (95% confidence interval [CI] 10, 12) of the male respondents who did not have any sexual risk, 24% (95% CI 22, 26) of HRH respondents, and 38% (95% CI 31, 45) of MSM ( Figure 1 ). Compared with men with no sexual risk, HRH respondents were more than twice as likely (unadjusted RR52. 29 Among all HRH respondents, the multivariable model indicated that receipt of a physical examination, testing or treatment for STIs, having government health insurance other than Medicaid (Medicare, military, or Veterans Administration), and having spent time in jail, prison, or a juvenile detention facility in the prior 12 months were independently associated with a higher likelihood of having HIV testing in the prior 12 months (Table 2 ). Among HRH respondents who received HIV testing in the prior 12 months, 39% (95% CI 34, 45) received their most recent HIV test at a private clinic, and 22% (95% CI 19, 27) received their most recent test at a community health clinic ( Figure 3 ). For 2006-2010, the most frequently cited reasons for obtaining the most recent HIV test were as follows: "wanted to find out if infected or not" (49%, 95% CI 43, 55), "testing was part of a medical checkup or surgical procedure" (24%, 95% CI 19, 30), "possible exposure through sex or drug use" (7%, 95% CI 4, 10), and "for military service or a job" (7%, 95% CI 3, 12).
Among MSM, HIV testing in the prior 12 months was independently associated with testing or treatment for an STI other than HIV and with having spent time in jail, prison, or a juvenile detention facility in the prior 12 months ( (Figure 3 ). For 2006-2010, the most frequently cited reasons for their most recent HIV test were as follows: "wanted to find out if infected or not" (46%, 95% CI 33, 60), "testing was part of a medical checkup or surgical procedure" (20%, 95% CI 11, 32), and "possible exposure through sex or drug use" (18%, 95% CI 8, 38).
DISCUSSION
Our analysis of data from a nationally representative sample suggests low adherence to the 2006 recom-mendations for annual HIV testing among men with sexual risk for HIV infection in the years immediately following the recommendations. Fewer than half of HRH and MSM respondents had received HIV testing in the prior 12 months, with no significant change after the 2006 revised CDC HIV testing recommendations. Similarly, analysis of data from the 2003-2010 National Health and Nutrition Examination Survey (NHANES) showed that HIV testing did not change significantly among high-risk groups, including MSM, before and after the 2006 CDC guidelines, although testing among males increased modestly. 11 Our findings differ from those reported in an 12, 13 Compared with the exclusively urban, venue-visiting MSM surveyed in NHBS, NSFG respondents represent more of a general cross-section of MSM, including those residing in rural locations who may have been less likely to receive HIV testing because of less accepting social or sexual environments for MSM, concerns about loss of confidentiality, limited access to HIV testing, underestimation of their personal risk for HIV, or fear of testing positive. [14] [15] [16] A few U.S. studies showed that people living in rural areas are less likely than those living in urban areas to report prior HIV testing and, if HIV infected, more likely to be diagnosed late and to delay entry to HIV care. [17] [18] [19] Additionally, given that 16% of MSM surveyed in NSFG identified as heterosexual or straight, a significant minority may not test annually out of concern about loss of confidentiality. [20] [21] [22] Because NSFG uses a nationally representative sample, our results provide useful additional data to existing surveillance data to better understand HIV testing behaviors of MSM in the United States. When we examined the use of health-care services and HIV testing to assess whether men at risk who utilized health-care services were more or less likely to have received HIV testing, we found that most HRH respondents and MSM had health insurance and approximately half had received a physical examination in the prior 12 months. However, among men who received a physical examination, fewer than half reported HIV testing needed, because testing is the key first step in HIV treatment and prevention. 27, 28 Limitations Limitations of this study included a self-reported history of HIV testing, which may have been subject to recall errors, particularly in the setting of opt-out testing, in which HIV testing is performed routinely (i.e., without pretest counseling and informed consent) unless a patient explicitly refuses. However, it is unlikely that opt-out testing was a prevalent practice during the years of the survey: CDC recommended opt-out testing in medical settings in 2006, and evidence suggests low uptake of opt-out HIV testing in the first few years after the revised recommendations. 5, 29, 30 Additionally, because HIV status was not assessed by NSFG, the sample may have included respondents who had previously tested positive for HIV, some of whom may not have needed to be tested in the prior 12 months. Had we been able to remove these previously diagnosed people with no need for testing from the denominator, our estimate of the proportion of undiagnosed people tested for HIV in the prior 12 months might have been slightly higher. The impact of this limitation was likely minimal, because the prevalence of HIV infection in the general population is approximately 0.5% and approximately 9% among MSM. [31] [32] [33] [34] We did not define injection drug use as a risk behavior in this analysis because our objective was to evaluate HIV testing in relation to sexual risk behavior. Additionally, the percentage reporting injection drug use in the prior 12 months was minimal (1% among HRH respondents and 2% among MSM) and unlikely to be a substantial confounding factor. Our findings for MSM should be cautiously interpreted, because the number of MSM surveyed by NSFG was relatively small; the surveys did not oversample MSM, and the power to detect differences among MSM across years was low. Finally, the survey data in our analysis preceded legislative measures enacted since 2010 to promote opt-out testing (e.g., the Veterans Health Administration eliminated the requirement for written informed consent in August 2009) 35 and preceded the enactment of the Affordable Care Act, 36 which mandates that health insurance plans cover HIV screening. Thus, more recent surveys may find increased uptake of annual HIV testing among MSM and other people at risk for HIV infection.
CONCLUSION
Our analysis demonstrated that a low proportion of men at high risk for HIV infection received HIV testing in the prior year, and testing did not increase appreciably from 2002 to 2006-2010, despite CDC's expanded HIV testing recommendations in 2006. More provider training and patient education might have helped increase uptake of annual HIV testing for MSM who utilized routine medical services, and might still help today. Interventions are critically needed to increase uptake of annual HIV testing for men at risk, especially for MSM, in both nonmedical and health-care settings.
